Sustainability
WuXi Biologics secures ISO 20400 certification
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
- By IPP Bureau
| January 07, 2026
Cementing its leadership in sustainable supply chains, WuXi Biologics has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized benchmark that embeds sustainability into procurement practices while promoting transparency and responsibility across the supply chain.
The certification underscores the company’s strong performance in sustainability and its commitment to building a resilient supply chain.
Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, said, “As a member and active participant of PSCI, WuXi Biologics adheres to world-leading management strategies to build a robust supply chain that ultimately serves as the value chain empowering sustainable business growth.
"We deliver high-quality solutions to meet global client demands while making active contributions that spearhead responsible value chain advancement in the pharmaceutical industry.”
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management—from due diligence and onboarding to risk management, engagement, performance review, and termination.
The approach ensures suppliers consistently meet quality, compliance, and sustainability standards, while promoting transparency, traceability, and operational efficiency. It also drives responsible practices across the company’s supplier network.
Recognizing the urgency of climate change, WuXi Biologics has adopted an integrated strategy with measurable SBTi targets and detailed roadmaps. Beyond pursuing its own climate goals, the company actively collaborates with suppliers through sustainable supply chain management, creating positive environmental impacts across the entire value chain.
